Which GLP 1 Is Best for Weight Loss? Comparing Medications, Results, and Costs

Last updated: November 18, 2026
Quick Answer
Tirzepatide (sold as Zepbound) produces the largest average weight loss among currently approved GLP-1 class drugs, with trial data showing roughly 20% body weight reduction compared to about 15% for semaglutide (Wegovy) and 8% for liraglutide (Saxenda) [1]. The “best” choice still depends on your health history, budget, and tolerance for side effects, not just the numbers on a chart.
Choosing between these medications isn’t a one-size question. A 46-year-old with type 2 diabetes and heart disease risk has different priorities than a 28-year-old without diabetes who wants the most pounds lost per dollar spent. This guide to which GLP 1 is best for weight loss, comparing medications, results, and costs breaks down the real data so you can have a more informed conversation with a prescriber.
7 Best GLP-1 Providers Ranked: Accreditation, Flexibility & Support Compared (2026 Update)
32,000+ Patients Can't All Be Wrong: See the Top-Rated GLP-1 Providers. We compared the leading online GLP-1 providers based on program features, clinical support, convenience, and overall value.
BMI MD GLP-1 Microdosing Plan
- Specialized microdosing options, including sublingual drops and low-dose injections
- Designed for people interested in maintaining weight or gradually adjusting treatment
- Bundled program structure without a separate monthly platform membership
- Online access makes the process convenient from home
DirectMeds Weight Loss Solutions
- Online weight-loss program with a straightforward patient experience
- Compounded medication options through state-licensed compounding pharmacies
- Includes clinical consultation as part of the process
- Provides shipping updates to help patients track their orders
MEDVi Flat-Rate Telehealth
- Flat-rate telehealth approach designed for easier budgeting
- No dosage-based pricing increases within the advertised program structure
- Offers injectable and oral thin-film delivery options
- Includes medical screening and asynchronous provider consultations
Gala GLP-1 Care Program
- Text-based access to state-licensed clinicians
- Cold-chain medication shipping included in the program
- Month-to-month program structure
- Designed for people who value convenient ongoing support
Measured GLP-1 Metabolic Health
- Comprehensive metabolic health screening and intake analysis
- Designed around longer-term metabolic health management
- Responsive dashboard with integrated health tracking tools
- Useful option for patients who value a more data-focused experience
Refills GLP-1 (TryRefills Plan)
- Clinical guidance designed to help patients manage common treatment concerns
- Includes foundational nutritional strategies alongside medication
- Designed around predictable ongoing treatment
- No hidden startup or processing fees according to the program information provided
AltRx GLP-1 Transactional Reorders
- Transactional reorder model without recurring auto-billing
- Designed for patients who already understand their treatment routine
- Fast text-to-order process for convenient reorders
- Offers injectable and fast-dissolving tablet variations
Key Takeaways
- Tirzepatide (Zepbound/Mounjaro) delivers the highest average weight loss of approved GLP-1 class drugs, around 19-20% of body weight [1][2].
- Semaglutide (Wegovy) is close behind at roughly 15-19%, with added cardiovascular benefit data that may matter for some patients [1][3].
- Liraglutide (Saxenda) is the oldest and least potent option, averaging about 8% weight loss [1].
- List prices run $1,000+ per month without insurance, but manufacturer savings programs can bring self-pay costs down substantially.
- The WHO’s first global obesity guideline, issued December 2025, now endorses GLP-1 and GIP/GLP-1 drugs as long-term obesity treatment for adults with BMI 30+ [4][5][6].
- Weight regain is common after stopping treatment, which is why WHO guidance frames these drugs as part of long-term chronic care, not a short course [6][7][8].
- Compounded versions are not FDA-approved and should be approached with caution and medical oversight.
- Newer agents like retatrutide and CagriSema are showing even larger average losses in trials, though they remain investigational [2].
What is a GLP-1 medication and how does it actually work
GLP-1 medications mimic a natural gut hormone called glucagon-like peptide-1, which slows stomach emptying, reduces appetite signals in the brain, and helps regulate blood sugar. This combination leads most people to eat less without constant hunger.

Some newer drugs, like tirzepatide, also activate a second hormone receptor called GIP, which appears to add extra metabolic benefit. That dual-action mechanism is a big reason tirzepatide outperforms single-action GLP-1 drugs in head-to-head weight loss data [1][2]. For readers who want the biology explained in more depth, our breakdown of how Ozempic helps you lose weight covers the science in plain language.
Choose a GLP-1 drug if you have obesity or weight-related health conditions and have already tried diet and lifestyle changes without lasting results. These medications are not designed for cosmetic weight loss of a few pounds.
Ozempic vs Saxenda vs Mounjaro: which one works best for weight loss
Among these three, Mounjaro (tirzepatide) produces the greatest average weight loss, Ozempic (semaglutide) comes in second, and Saxenda (liraglutide) trails both by a wide margin. This ranking holds up consistently across comparative analyses [1][2].
| Medication | Active ingredient | Average weight loss | Dosing | FDA approval for weight loss |
|---|---|---|---|---|
| Mounjaro / Zepbound | Tirzepatide | ~19-20% | Weekly injection | Zepbound approved; Mounjaro is diabetes-labeled |
| Ozempic / Wegovy | Semaglutide | ~15-19% | Weekly injection or daily pill (Wegovy) | Wegovy approved; Ozempic is diabetes-labeled |
| Saxenda | Liraglutide | ~8% | Daily injection | Approved for weight loss |
A practical decision rule: choose tirzepatide-based Zepbound if you want the strongest average results and can tolerate injection therapy. Choose semaglutide if you have cardiovascular risk factors, since Wegovy carries an added indication for reducing cardiovascular events in some patients [3]. Choose liraglutide only if newer drugs aren’t accessible or appropriate for you, since it requires daily injections for comparatively modest results.
A common mistake is assuming Ozempic and Wegovy are interchangeable. They contain the same drug, semaglutide, but Ozempic is FDA-approved for diabetes and Wegovy for chronic weight management. See our detailed Zepbound vs Ozempic comparison and Wegovy vs Mounjaro breakdown for more nuance.
How much weight can you realistically lose on GLP-1 medication
Realistic expectations depend on the specific drug, your starting weight, and how long you stay on treatment. Clinical data suggests tirzepatide users lose an average of around 50 pounds, Wegovy injection users around 35 pounds, and Saxenda users around 21 pounds over the course of a trial period [9].
These are averages, not guarantees. Individual results vary widely based on dose, diet adherence, activity level, and metabolism. A 2026 analysis found that even pushing semaglutide to a higher 7.2 mg dose only added about 2-3 extra percentage points of weight loss compared to the standard 2.4 mg dose, a gain that may not be worth added side effects for everyone. For a realistic week-by-week picture, our Ozempic weight loss results and 6-week plan walks through what early progress typically looks like.
How much does Ozempic cost without insurance
Ozempic and similar GLP-1 drugs list for roughly $1,000 to $1,350 per month without insurance, though actual out-of-pocket costs vary significantly based on manufacturer programs and pharmacy. Mid-2026 pricing data shows Zepbound injection listing around $1,060 per month and Wegovy around $1,349 per month.
Manufacturer self-pay programs can lower costs substantially:
- Zepbound: roughly $299-$499 per month through manufacturer savings programs
- Wegovy injection: roughly $199-$399 per month
- Wegovy pill: roughly $149-$299 per month
Choose the manufacturer’s direct savings program if you’re paying out of pocket, since it typically beats standard retail pharmacy pricing by a wide margin. For a full cost breakdown across brands, see our GLP-1 weight loss cost guide and our TrumpRx weight loss prices overview.
Does insurance cover GLP-1 injections for weight loss
Insurance coverage for weight-loss GLP-1 drugs remains inconsistent, though a new Medicare demonstration project is expanding access. Since July 1, 2026, eligible Medicare Part D enrollees can access selected GLP-1 drugs for weight reduction through the Medicare GLP-1 Bridge demonstration project at a $50 monthly co-pay, with coverage running through December 31, 2027 [10].

Private insurance coverage still varies by employer and plan, and many plans exclude weight-loss indications even when they cover the same drug for diabetes. Check with your specific insurer, and ask your prescriber’s office to run a prior authorization request before assuming you’re uncovered. Our guide on whether Kaiser covers GLP-1 for weight loss is a useful example of how one large insurer handles this.
What are the most common side effects of GLP-1 drugs
The most common side effects across all GLP-1 medications are gastrointestinal: nausea, diarrhea, constipation, and vomiting, especially during dose increases. These symptoms often improve after the first several weeks as the body adjusts.
Less common but more serious risks include pancreatitis, gallbladder problems, and in rare cases, a risk of thyroid tumors seen in animal studies (the reason these drugs carry a warning against use in people with a personal or family history of certain thyroid cancers). A common mistake is increasing doses too quickly to speed up results, which usually just worsens nausea without adding meaningful extra weight loss. Always follow your prescriber’s titration schedule rather than your own.
Can you take GLP-1 if you have diabetes or thyroid problems
If you have type 2 diabetes, GLP-1 drugs are often appropriate and may improve blood sugar control alongside weight loss, but the specific drug and dose should be chosen with your doctor. If you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, GLP-1 drugs are generally not recommended due to a boxed warning about thyroid tumor risk seen in animal studies.
Edge case: people with well-managed hypothyroidism (not thyroid cancer) are usually still candidates for GLP-1 therapy, since the warning applies specifically to certain thyroid cancer risks, not thyroid conditions broadly. Always disclose your full thyroid and endocrine history during your consultation.
What happens to your weight when you stop taking GLP-1
Most people regain a significant portion of lost weight after stopping GLP-1 medication, because the drug’s appetite-suppressing effect fades once it leaves the body. This is one reason the World Health Organization’s December 2025 guideline frames GLP-1 therapy as a long-term chronic-care tool rather than a short-term fix [4][6][7][8].
Weight regain isn’t inevitable for everyone, but it’s common enough that prescribers generally recommend a maintenance plan before stopping. For a closer look at this pattern, read what happens when you stop taking Ozempic and our guide to tirzepatide maintenance dosing after reaching goal weight.
Are there other weight loss medications besides GLP-1
Yes. Options outside the GLP-1 class include older prescription drugs like phentermine-topiramate and naltrexone-bupropion, along with newer investigational multi-agonist drugs still in trials. A 2026 comparative analysis found the investigational triple agonist retatrutide produced the greatest average weight loss (-22.10%) in trials, ahead of tirzepatide (-19.28%) and the semaglutide-cagrilintide combination CagriSema (-17.32%), though none of these are yet FDA-approved for general use [2].
Choose a non-GLP-1 prescription option if you’ve been advised against GLP-1 drugs due to thyroid history or another contraindication. Our prescription weight loss medication guide covers alternatives in more detail.
How long does it take to see results on GLP-1
Most people notice reduced appetite within the first one to two weeks, with measurable weight loss typically becoming visible by week four to six. Significant results, in the range of 10% or more of body weight, generally take three to six months of consistent use and proper dose titration.

A common mistake is judging progress too early, before the dose has been fully titrated up. Weight loss tends to accelerate once you reach the maintenance dose, not during the initial low-dose weeks.
Who is not a good candidate for GLP-1 medications
GLP-1 drugs are not appropriate for pregnant or breastfeeding individuals, people with a personal or family history of medullary thyroid carcinoma, and those with a history of multiple endocrine neoplasia syndrome type 2. The WHO’s December 2025 obesity guideline specifically excludes pregnant women from its recommendations [4][5][6].
People with active gallbladder disease, severe gastroparesis, or a history of pancreatitis should discuss these risks carefully with a doctor before starting treatment, since GLP-1 drugs can worsen these conditions.
Is compounded GLP-1 as effective as brand name
Compounded GLP-1 medications are not FDA-approved products, and their effectiveness and safety have not been verified through the same regulatory process as brand-name drugs like Wegovy, Zepbound, Ozempic, or Saxenda. Compounded versions may use different formulations, purity standards, or dosing, which means outcomes cannot be assumed to match clinical trial data.
Choose an FDA-approved brand medication if consistent, verified dosing matters most to you. If cost is driving you toward compounded options, review the risks carefully with a licensed provider first, and compare legitimate online pharmacy options through resources like our guide to the best places to get GLP-1s online.
Do you still need to diet and exercise while on GLP-1
Yes. The World Health Organization’s guidance explicitly recommends using GLP-1 therapy within a comprehensive approach that includes healthy diet, physical activity, and behavioral support, not as a standalone solution [6][7][8]. Diet and exercise also help preserve lean muscle mass, which medication alone does not address.
Skipping nutrition and activity planning is a common mistake that can lead to muscle loss alongside fat loss, plus a higher chance of regain once treatment stops.
What’s the difference between Ozempic for diabetes vs weight loss
Ozempic is FDA-approved specifically for type 2 diabetes management, while Wegovy, which contains the identical active ingredient (semaglutide) at a higher maintenance dose, is FDA-approved for chronic weight management. Doctors sometimes prescribe Ozempic off-label for weight loss, but Wegovy is the version actually studied and approved for that purpose.
This distinction matters for insurance, since plans that cover diabetes medication may deny the same drug when billed for weight loss. Our semaglutide weight loss medication guide explains the dosing differences in detail.
FAQ
Which GLP-1 drug causes the most weight loss?
Tirzepatide, sold as Zepbound for weight loss, currently shows the largest average weight loss among approved GLP-1 class drugs, around 19-20% of body weight in trial data [1][2].
Is Wegovy or Zepbound better for weight loss?
Zepbound has shown somewhat greater average weight loss than Wegovy in head-to-head cost-effectiveness analysis (-20.2% versus -13.7%), though individual response varies and Wegovy carries added cardiovascular benefit data.
How much weight will I lose in the first month on GLP-1?
Early weight loss in month one is usually modest, often in the range of a few pounds, since doses start low. Most significant loss happens after reaching the maintenance dose around month three or later.
Can I lose weight on GLP-1 without changing my diet?
Some weight loss may occur from appetite suppression alone, but the World Health Organization recommends pairing GLP-1 therapy with diet and activity changes for the best and most sustainable results [6][7].
Does Medicare cover GLP-1 for weight loss in 2026?
Yes, for some enrollees. The Medicare GLP-1 Bridge demonstration project, active since July 1, 2026 and running through December 2027, offers eligible Part D enrollees access to select GLP-1 drugs at a $50 monthly co-pay [10].
Is semaglutide safe for long-term use?
Semaglutide has been studied for extended use in clinical trials, and WHO guidance now frames GLP-1 drugs as long-term chronic-care treatments for eligible adults with obesity [4][6]. Long-term safety should still be monitored by your prescriber.
What’s the cheapest GLP-1 option for weight loss?
Pricing varies by program and manufacturer discount. Oral Wegovy pill access through manufacturer savings programs has been among the lower-cost GLP-1 options reported, around $149-$299 per month as of mid-2026.
7 Best GLP-1 Providers Ranked: Accreditation, Flexibility & Support Compared (2026 Update)
32,000+ Patients Can't All Be Wrong: See the Top-Rated GLP-1 Providers: Compared on accreditation, plan flexibility, and patient support — updated for 2026.
BMI MD GLP-1 Microdosing Plan
- Specialized microdosing options (sublingual drops or low-dose injections)
- Ideal for maintaining weight or tapering off higher doses safely
- Fully bundled plan with no hidden monthly platform memberships
DirectMeds Weight Loss Solutions
- Sourced from accredited, state-licensed 503A compounding pharmacies
- No-frills high-volume savings passed directly to the patient
- Includes clinical consultation and cold-chain shipping updates
MEDVi Flat-Rate Telehealth
- Flat monthly rate holds steady even at maximum maintenance doses
- No dosage upcharges or graduation fee penalties
- Offers both injectable and advanced oral thin-film delivery options
Gala GLP-1 Care Program
- All-inclusive plan with no standalone membership costs
- Continuous text-based messaging access with state-licensed clinicians
- Temperature-controlled, cold-chain medication shipping included
Measured GLP-1 Metabolic Health
- Comprehensive metabolic health screening and expert intake analysis
- Predictable long-term budgeting with stable plan pricing
- High-end responsive dashboard with integrated diagnostic support
Refills GLP-1 (TryRefills Plan)
- Flat rate holds steady as titration scales up
- Includes clinical guides for active side-effect management
- Bundles in foundational nutritional strategies alongside medication
AltRx GLP-1 Transactional Reorders
- Zero recurring auto-billing — pay entirely on a transactional basis
- Rapid text-to-order format saves time for experienced patients
- Provides both injectable forms and fast-dissolving tablet variations
Conclusion
So, which GLP-1 is best for weight loss when you compare medications, results, and costs side by side? Tirzepatide-based Zepbound currently leads on average weight loss, semaglutide-based Wegovy follows closely with added cardiovascular data, and liraglutide trails both but remains an option when newer drugs aren’t suitable. The right answer for you depends on your health conditions, budget, and how your body tolerates each medication, not just which one ranks highest in a trial.
Before starting any GLP-1 medication, talk with a licensed healthcare provider about your full medical history, including thyroid and pancreatic health, and ask directly about manufacturer savings programs or insurance pathways that could lower your cost. If you’re still comparing providers and options, our 7 GLP-1 options compared for 2026 is a good next stop.
References
- Which Glp 1 Medication Is Most Effective for Weight Loss. rx.uga.edu.
- pubmed.ncbi.nlm.nih.gov.
- Glp 1 Drug Best Weight Loss. drugs.com.
- 01 12 2025 Who Issues Global Guideline on the Use of Glp 1 Medicines in Treating Obesity. who.int.
- JAMA Network. jamanetwork.com.
- Obesity GLP-1 Therapies Q&A. who.int.
- WHO Guideline Use Glucagon Peptide 1 Therapies. paho.org.
- From Evidence To Action: WHO Guideline Event. who.int.
- GLP-1 Comparison Chart. beyondtype1.org.
- ObesityWeek 2026 Studies Map GLP-1 Access Gaps. ajmc.com.
